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Background Work-related rhinitis and asthma symptoms frequently co-exist.
Aims To determine the prevalence and nature of nasal, pharyngeal, laryngeal and sinus symptoms among 
individuals with work-related respiratory symptoms.
Methods Individuals referred to a tertiary occupational asthma clinic for investigations with specific inhalation 
challenges were evaluated using the RHINASTHMA quality of life questionnaire and a question-
naire that assessed the nature and frequency of upper airway symptoms, their relationship to the 
workplace and their temporal relationship with the onset of asthma symptoms.
Results There were 83 study participants. At least one upper airway symptom was reported by all of these 
individuals: nasal in 92%; pharyngeal in 82%; laryngeal in 65% and sinus in 53% of participants. 
Overall, there were no significant differences in the frequencies of nasal, pharyngeal, laryngeal and 
sinus symptoms when comparing these with occupational asthma (OA), work-exacerbated asthma 
(WEA) and work-related respiratory symptoms (WRS), except that nasal bleeding was most fre-
quent among those with WRS. The presence of laryngeal symptoms was significantly associated with 
rhinitis-specific quality of life impairment. Individuals with workplace exposures to high molecular 
weight agents had greater impaired quality of life than those who were exposed to low molecular 
weight agents (RHINASTMA Upper Airway sub-scores: 24.0 ± 10.4 versus 19.8 ± 6.8; P < 0.05).
Conclusions Individuals who were referred for work-related respiratory symptoms experienced high rates of 
work-related nasal, pharyngeal, laryngeal and sinus symptoms, regardless of having OA, WEA or 
WRS.
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Introduction
The nose is the respiratory system’s first defence mecha-
nism against airborne contaminants, including occupa-
tional allergens and irritants. Thus rhinitis is frequently 
the first clinical manifestation of respiratory problems, 
which can often extend to the lower airways and mani-
fest as asthma at a later stage. In the workplace workers 
are exposed to a variety of allergens and chemicals that 
can potentially cause different respiratory symptoms. 
Workplace exposures to high molecular weight (HMW) 
agents and low molecular weight (LMW) agents are 
associated with a wide spectrum of conditions that can 
range from mucous membrane irritation and aggra-
vation of pre-existing rhinitis and asthma to clinically 
established occupational rhinitis (OR) and occupational 
asthma (OA) [1].
There is an extensive literature on the links between 
the upper and lower airways, although most available 
evidence describes the co-expression of rhinitis and 
asthma symptoms in the general population [2]. However 
there is sufficient evidence to show that these relationships 
also apply to rhinitis and asthma symptoms that are of 
occupational origin [3,4]. However, surprisingly little 
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has been published on the frequencies of pharyngeal, 
laryngeal and sinus symptoms among workers that 
manifest as work-related respiratory symptoms.
In this study, we characterized the nature and fre-
quency of upper airway symptoms (nasal, pharyngeal, 
laryngeal and sinus) and the severity of rhinitis symptoms 
both ‘at work’ and ‘away from work’ among subjects with 
complaints of work-related respiratory symptoms. These 
individuals had been evaluated using specific inhalation 
challenges (SIC) and were also diagnosed with either 
OA, work-exacerbated asthma (WEA) or work-related 
respiratory symptoms (WRS). We also examined the 
impact of rhinitis and asthma symptoms on quality of life 
(QOL) using a disease-specific questionnaire and deter-
mined if the frequency and nature of symptoms differed 
according to the type of occupational agents to which 
these workers were exposed.
Methods
We recruited subjects who had been referred to a ter-
tiary clinic specializing in occupational respiratory dis-
eases for the evaluation of WRS. Each subject completed 
a disease-specific QOL questionnaire and a question-
naire on upper airways symptoms. An initial investigation 
included a detailed medical and occupational history 
and skin prick testing to common aeroallergens to assess 
atopy. Atopy was defined as at least one positive reaction 
to a common aeroallergen.
Each subject then underwent an SIC using both 
a control agent and the suspected occupational agent. 
A diagnosis of OA was established based on a positive 
SIC result. A diagnosis of WEA was based on a negative 
SIC result and a positive methacholine test result defined 
as PC20 ≤ 16 mg/ml [4]. Subjects who did not meet these 
diagnostic criteria were categorized as having WRS. For 
this study, we assumed that exposure to the suspected 
occupational agent was responsible for both lower and 
upper respiratory symptoms. This study was approved by 
the hospital medical ethics committee and all study par-
ticipants gave their written informed consent.
Each subject completed a questionnaire regarding 
the nature and frequency of upper airway symptoms, 
symptoms’ relationships to the workplace and symp-
toms’ temporal relationships with the onset of asthma 
symptoms (either prior to, at the same time or after 
onset). This questionnaire was based on the standard-
ized questionnaire of the International Union against 
Tuberculosis and Lung Disease and the 1988 National 
Health Interview Survey occupational health sup-
plement [5,6]. In this questionnaire, symptoms were 
grouped as nasal, pharyngeal, laryngeal and sinus. Nasal 
symptoms included obstruction, rhinorrhoea, sneez-
ing, itching, nasal bleeding, nasal crusting and impaired 
olfaction. Pharyngeal symptoms included sore throat, 
throat dryness, throat clearing and throat burning. 
Laryngeal symptoms included dry cough and hoarse-
ness. Sinus symptoms included mucopurulent nasal dis-
charge, facial pain/pressure and post-nasal drip.
Subjects also completed the RHINASTHMA ques-
tionnaire [7]. This consisted of 30 items regarding the 
impact of rhinitis and asthma while subjects were work-
ing, recorded on a five point Likert scale (not at all, a lit-
tle, fairly often, often, very often). Questionnaire response 
analysis provided sub-scores related to the Upper Airways 
(UAS), Lower Airways (LAS), Respiratory Allergy 
Impact (RAI) and a Global Score (Global Summary). 
Answers to the RHINASTHMA items were then con-
verted to scores ranging from 0 (minimal impact) to 100 
(maximum impact). Both questionnaires were adminis-
tered on the first day of the scheduled investigation prior 
to the clinical investigation and SIC.
A visual analogue scale (VAS) ranging from 0 (not at 
all bothersome) to 10 (extremely bothersome) was used 
to assess the severity of combined rhinitis symptoms 
both ‘at work’ and ‘away from work’ [8].
SICs were performed according to a previously 
described methodology following international rec-
ommendations [9]. On the first day, a subject was 
exposed to a control substance to ensure that asthma, 
if present, was stable. On subsequent days, a subject 
was progressively exposed to increasing doses of the 
occupational agent suspected of causing the respira-
tory symptoms. After the control and active challenge 
were administered, FEV1 was monitored at regular 
intervals for 6 h. A methacholine test was performed 
at the end of the control and last active challenge day. 
A SIC was considered positive if there was a decline in 
FEV1 of ≥ 20% [9].
Results for categorical variables are given as absolute 
numbers and relative frequencies (percentages). Results 
for continuous variables are given as means ± SDs or as 
medians and 25th and 75th percentiles for non-normally 
distributed variables. Categorical frequencies were 
compared using a Chi-squared or Fisher’s exact test. 
Continuous variables were compared using Student’s 
t-test or Mann-Whitney U test. Spearman’s rho was used 
for correlation analysis. We created binary categorical 
variables for each of the groups of upper airways symptoms 
(Nasal_Symptoms, Pharyngeal_Symptoms, Laryngeal_
Symptoms and Sinus_Symptoms). For example, a subject 
was categorized as having nasal symptoms if he reported 
having one or more of the several symptoms in the nasal 
symptoms group. Individual scores from the Rhinasthma 
UAS were log-transformed to generate a near-normal 
distribution. We then did a linear regression analysis 
using the UAS sub-scores as the dependent variables and 
the variables of Nasal_Symptoms, Pharyngeal_Symptoms, 
Laryngeal_Symptoms and Sinus_Symptoms as predictors. 
Data analyses used SPSS V.19 (SPSS, Inc., Chicago, IL, 
USA). 
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Results
There were 83 study participants. The study subjects’ 
baseline characteristics are shown in Table 1. After SICs, 
29 (35%) were diagnosed with OA, 21 (25%) were diag-
nosed with WEA and 33 (40%) were diagnosed with 
WRS. These three groups were comparable with respect 
to age and gender (data not shown).
At least one symptom was frequently reported by all 
of the study subjects: nasal 92% (76/83); pharyngeal 
82%; laryngeal 65% and sinus 53%. Most of the study 
subjects reported that upper airways symptoms occurred 
‘almost every day’ or ‘one day or more per week.’ Also all 
categories of upper airways symptoms were reported as 
occurring more often in the workplace than when away 
from work (Figure 1).
In general, there were high frequencies of upper 
airway symptoms among all of the SIC diagnosis groups 
(Table  2). Nasal symptoms and pharyngeal symptoms 
were reported by the majority of individuals who were 
referred for investigating work-related respiratory 
symptoms. However, there were no significant differences 
in the frequencies of nasal, pharyngeal, laryngeal and 
sinus symptoms after comparing the subjects with 
OA, WEA and WRS, except that ‘nasal bleeding’ was 
significantly more frequent among subjects with a final 
diagnosis of WRS.
Nasal symptoms more frequently preceded those of 
asthma among subjects with OA (56%) as compared 
with subjects with WEA (40%). In contrast, pharyngeal 
symptoms more frequently preceded those of asthma 
among subjects with WEA (38%) compared with sub-
jects with OA (29%). The same patterns were observed 
regarding laryngeal (OA: 40% versus WEA: 50%) and 
sinus (OA: 46% versus WEA: 56%) symptoms. However, 
these differences between the groups were not statisti-
cally significant (Table 2).
From univariate analysis, the symptom categories 
of Throat_Symptoms, Larynx_Symptoms and Sinus_
Symptoms were statistically significantly associated with 
Rhinasthma UAS. In our model 6, after incorporating 
all of the symptom categories and controlling for sex and 
age, only Larynx_Symptoms remained significantly asso-
ciated with Rhinasthma UAS (Table 3).
Subjects who were exposed at work to HMW agents 
reported higher frequencies of nasal and sinus symp-
toms, while subjects who were exposed to LMW agents 
reported higher frequencies of pharyngeal and laryn-
geal symptoms; however these observed differences in 
individual symptom categories were not statistically 
significant (data not shown). In addition, as shown in 
Table  4, QOL assessed by the Rhinasthma question-
naire indicated that those exposed to HMW agents had 
greater impairments in QOL than those exposed to 
LMW agents (24.0 ± 10.4 versus 19.8 ± 6.8; P < 0.05).
Subjects had significantly higher VAS scores ‘at 
work’ as compared with VAS scores ‘away from work’ 
(4.7 ± 3.0 versus 2.4 ± 2.7; P < 0.001). Rhinitis symp-
toms ‘at work’ were considered as moderate/severe by 
59% and mild by 41% of these subjects. In contrast, 
only 23% of these subjects considered rhinitis symp-
toms ‘away from work’ as moderate/severe and 77% 
regarded these symptoms as mild. A  comparison of 
rhinitis severity levels ‘at work’ and ‘away from work’ 
based on the final diagnosis after SIC showed the same 
pattern, with significantly higher VAS scores ‘at work’ 
as compared with ‘away from work’ in all groups: for 
OA, at work median = 5.0 (25th percentile, 75th per-
centile: 2.6, 7.2) versus away from work: 2.7 (0.5, 5.0); 
P = 0.001; for WEA, 4.0 (0.6, 6.0) versus 0.8 (0.2, 4.0); 
P < 0.05 and for WRS, 5.7 (2.9, 8.2) versus 0.9 (0.3, 
3.2); P < 0.001. However, no statistically significant dif-
ferences were found between the SIC diagnosis groups.
Subjects who rated their rhinitis ‘at work’ as mod-
erate or severe reported significantly more rhinorrhea 
than subjects who rated rhinitis symptoms as mild 
(Table 5). However the differences in symptoms preva-
lence (sneezing and stuffy nose) as well as the difference 
in mean RAI sub-score and Global Summary score 
Table 1. Baseline characteristics of the study participants (n = 83)
Characteristics n (%)
Male: female 59 (71) : 24 (29)
Age, years 41.8 ± 10.8
Atopy 61 (74)
Smoking status, current : ex : never 20 (24) : 20 (24) : 43 (52)
Duration of exposure in years 8.0 (3.0; 21.0)
Oral antihistamines   9 (11)
Nose medication 10 (12)
Asthma medication 39 (47)
FEV1% predicted 95.8 (86.2; 106.4)
Nature of agents
HMW : LMW 27 (33) : 56 (67)
HMW agents
 Flour 14
 Animal proteins  5
 Various cereals  3
 Enzymes  2
 Other various agents  3
LMW agents
 Isocyanates 13
 Resins, glues, paints  7
 Formaldehyde  6
 Woods  6
 Welding fumes  4
 Acrylates  5
 Cleaning agents  2
 Other various agents 13
Results are n (%), mean ± SD or median (25th percentile,  
75th percentile).
FEV1, forced expiratory volume in one second; HMW, high molecular weight; 
LMW, low molecular weight. Other various HMW agents: e.g. seafood, drugs, 
enzymes, bio-aerosols. Other various LMW agents: e.g. persulfates, colophony, 
metals.
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were not significant. Subjects who rated their rhinitis 
as moderate or severe when they were ‘away from work’ 
had greater QOL impairments for all RHINASTHMA 
scores, although these differences in UAS scores were 
not significant.
Discussion
Individuals with work-related respiratory symptoms who 
were investigated in an OA referral centre reported high 
frequencies of various upper respiratory symptoms that 
included not only nasal symptoms but also a wide range 
of sinus, laryngeal and pharyngeal symptoms. Pharyngeal 
symptoms were most strongly related to impairments in 
rhinitis-specific QOL.
To our knowledge, this is the first comprehensive 
examination of upper airways symptoms in a study pop-
ulation with a history suggestive of work-related asthma. 
All of these individuals underwent specific inhalation 
testing, which is considered the reference standard for 
investigating OA, WEA and WRS. We made extensive 
evaluations of upper respiratory symptoms and also 
determined their impact on rhinitis and asthma-specific 
QOL for each individual in this study.
This study had several limitations. First, the sample 
size was small and the data collected were restricted to 
one specialized health centre only. Second, symptoms 
were self-reported and thus only represented subjective 
evidence of upper airways conditions that might have 
been over- or under-reported. Third, we did not do envi-
ronmental exposure assessments with which to link the 
upper airways symptoms reported by the study subjects. 
Considering the high prevalence of upper airways symp-
toms observed in this study, we cannot be certain of the 
extent of over-reporting in this study.
However, it is important to note that these sub-
jects had been referred to our hospital for OA investi-
gations. Thus they were selected based on their lower 
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Figure 1.  Upper airways symptoms and their frequency distributions based on occurrence when ‘at work’ (upper panel) and when ‘away from 
work’ (lower panel). Upper panel: answer to the question: What is (was), on average, the frequency of your symptoms (if the symptoms have actually 
stopped, answer for the period when you had symptoms)? Lower panel: answer to the question: While away from work, how often do your symptoms 
occur?
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airways symptoms and not for upper airways com-
plaints. In addition it is more likely that there would be 
under-reporting of symptoms in this type of study popu-
lation, as asthma-like symptoms engender greater con-
cerns, whereas upper-airways symptoms are often not 
perceived as significant health problems.
The respiratory tract extends from the nose to the 
lungs. Thus, exposures of the mucous membranes of 
the nose, sinuses, pharynx and larynx to allergens and 
irritants in the workplace should theoretically induce 
not only nasal symptoms but also pharyngeal, laryngeal 
and sinus symptoms. In the medical literature, these 
Table 2. Prevalence of upper airways symptoms and quality of life scores in the three SIC diagnosis groups
Characteristics OA  
(n = 29)
WEA  
(n = 21)
WRS  
(n = 33)
Nasal symptoms n (%)
Rhinorrhoea 24 (83) 14 (67) 25 (76)
Itching 19 (66) 13 (62) 18 (55)
Sneezing 25 (86) 16 (76) 26 (79)
Obstruction 22 (76) 15 (71) 23 (70)
Nasal bleeding  6 (21)  3 (15) 14 (42)*
Nasal crusting 17 (59) 15 (71) 23 (70)
Hyposmia 12 (41) 10 (50) 17 (52)
≥2 common nasal symptoms 25 (86) 16 (76) 26 (79)
≥3 common nasal symptoms 21 (72) 15 (71) 22 (67)
4 common nasal symptoms 17 (59) 10 (48) 16 (49)
≥2 less common nasal symptoms 11 (38) 10 (48) 20 (61)
Timing of nasal symptoms in relation to onset of asthma-like symptoms
 - Before 15 (56)  6 (40)  9 (36)
 - At the same time  9 (33)  7 (47) 10 (40)
 - After  3 (11)  2 (13)  6 (24)
Pharyngeal symptoms n (%)
Sore throat 14 (48) 12 (60) 21 (66)
Dry throat 17 (59) 12 (60) 21 (66)
Throat clearing 19 (66) 15 (71) 24 (73)
Throat burning 10 (35)  7 (33) 15 (46)
Timing of pharyngeal symptoms in relation to onset of asthma-like symptoms
 - Before  6 (29)  6 (38) 10 (42)
 - At the same time  9 (43)  7 (44) 10 (42)
 - After  6 (29)  3 (19)  4 (17)
Laryngeal symptoms n (%)
Dry cough 14 (48)  9 (43) 24 (73)
Hoarseness 14 (48)  9 (43) 24 (73)
Timing of laryngeal symptoms in relation to onset of asthma-like symptoms
 - Before  6 (40)  5 (50)  6 (28)
 - At the same time  5 (33)  4 (40) 13 (62)
 - After  4 (27)  1 (10)  2 (10)
Sinus symptoms n (%)
Mucopurulent nasal discharge  8 (28)  6 (29)  8 (24)
Facial pain/pressure 11 (38)  5 (24) 15 (46)
Postnasal drip 13 (45)  9 (43) 16 (49)
Timing of sinusal symptoms in relation to onset of asthma-like symptoms
 - Before  6 (46)  5 (56)  9 (53)
 - At the same time  5 (39)  3 (33)  7 (41)
 - After  2 (15)  1 (11)  1 (6)
Rhinasthma quality of life scores (mean (SD))
UAS 22.2 (9.5) 20.1 (6.9) 21.2 (8.1)
LAS 32.8 (12.5) 33.7 (11.5) 33.1 (12.0)
RAI 20.5 (8.3) 17.5 (6.7) 18.6 (6.7)
Global summary 75.5 (27.9) 71.2 (22.1) 72.9 (22.9)
OA, occupational asthma; WEA, work-exacerbated asthma; WRS, work-related respiratory symptoms; UAS, upper airways sub-score; LAS, lower airway sub-score; 
RAI, respiratory allergy impact. *P < 0.05 between groups comparison. Common nasal symptoms = rhinorrhoea, obstruction, itching, sneezing. Less common nasal 
symptoms = nasal bleeding, nasal crusting, hyposmia.
432 OCCUPATIONAL MEDICINE
symptoms are not reported as frequently as work-related 
nasal symptoms, probably because nasal and bronchial 
symptoms are often more prominent and relevant for 
patients. Symptoms like dry throat, sore throat and 
throat clearing are frequently self-reported in occupa-
tional epidemiological surveys that focus on the preva-
lence of respiratory symptoms among workers exposed 
to diverse irritants (e.g. welding fumes, metal-working 
fluids) [10,11].
In addition, occupational pharyngitis and laryngi-
tis are less frequently reported as compared with OR. 
Kanerva et  al. reported on the occurrence of occupa-
tional pharyngitis that was confirmed by challenge tests 
using exposures to acrylate compounds that are used in 
orthodontics and dentistry [12]. Occupational laryngi-
tis has been reported in individuals who were exposed 
to formaldehyde, welding fumes and acrylate com-
pounds and chemicals used in hairdressing [13–16]. 
Occupational laryngitis often occurs concomitantly with 
OR or OA [17]. After analysing data from specialized 
clinics that investigated patients with WRA, Vandenplas 
et al. reported that loss of voice was negatively associated 
with the presence of OA to HMW agents [18].
The frequent co-existence of work-related rhinitis 
and asthma symptoms has been demonstrated in clinical 
and epidemiological studies [19]. We recently reported 
a high prevalence of rhinitis symptoms among subjects 
with a confirmed diagnosis of OA after SIC [1]. Other 
studies have found high frequencies of rhinitis symptoms 
among patients who were referred to specialized clinics 
for investigating work-related asthma [4,20]. In addition, 
the present study demonstrated that rhinitis symptoms 
‘at work’ were regarded as moderate or severe by a higher 
proportion of subjects and this severity pattern was asso-
ciated with a tendency for higher QOL impairment in 
the RAI and Global Summary scores of the Rhinasthma 
questionnaire.
A temporal relationship between work-related rhi-
nitis symptoms and the onset of work-related asthma 
symptoms has been documented in previous studies. 
Malo et al. showed that OR more often appeared before 
OA for exposures to HMW agents (58%) as compared 
with exposures to LMW agents (25%) [21]. Vandenplas 
et  al. showed that nasal symptoms less frequently pre-
ceded those of asthma in subjects with WEA (17%) 
than in those with OA (43%) [4]. Our study confirmed 
the results from these studies. However, in addition, we 
showed that pharyngeal, laryngeal and sinusal symp-
toms more frequently preceded those of asthma in sub-
jects with WEA than in those with OA. It remains to be 
determined if there is any clinical value in documenting 
pharyngeal, laryngeal and sinusal symptoms with respect 
to their potential to correctly identify patients with OA 
and WEA.
Generic QOL measures have been shown to be mod-
erately correlated with rhinitis symptoms scores and 
nasal hyperreactivity [22,23]. Nasal congestion and 
ocular symptoms were identified as the most disturbing 
symptoms that could decrease rhinitis specific QOL and 
work productivity [24,25]. Among greenhouse work-
ers, sensitization to bell pepper pollen had a negative 
impact on rhinitis-specific QOL scores and the pat-
tern in impairment was different when compared with 
individuals with non-occupational perennial rhinitis 
[26]. A  follow-up study of these workers showed that 
OR symptoms were a risk factor for a job change, but 
that symptom scores and rhinitis-specific QOL could 
return to baseline when complete exposure cessation 
was achieved [27]. However, continued exposure to the 
causative agent led to further declines in QOL among 
subjects with OR [28].
Table 3. Associations between different upper respiratory symptom categories and UAS scores from the Rhinasthma questionnaire (n = 83)
Log10(Rhinasthma UAS)
Covariates Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Nasal_Symptoms −0.32 (0.16) . . . −0.17 (0.17) −0.17 (0.17)
Pharyngeal_Symptoms . −0.27 (0.13)* . . −0.07 (0.14) −0.10 (0.14)
Laryngeal_Symptoms . . −0.39 (0.10)*** . −0.29 (0.12)* −0.27 (0.12)*
Sinus_Symptoms . . . −0.32 (0.10)** −0.16 (0.12) −0.13 (0.12)
Sex . . . . . −0.14 (0.11)
Age   0.01 (0.01)
Adjusted R2   0.03   0.04   0.16   0.11   0.18   0.21
UAS: upper airway score. Results are estimates of the regression coefficient, (standard error of the estimate) and statistical significance *P < 0.05, **P < 0.01, 
***P < 0.001, no indicator = P-value NS obtained by linear regression analyses. Models 1–4 are univariate analyses; model 5 incorporated all symptom categories as 
co-variates and model 6 incorporated all symptom categories variables and was adjusted for sex and age.
Table 4. Rhinasthma quality of life scores based on type of a 
etiologic agent (n = 83)
HMW (n = 27) LMW (n = 56) P-value
UAS 24.0 (10.4) 19.8 (6.8) *
LAS 31.9 (12.5) 33.8 (11.7)
RAI 19.3 (7.6) 18.8 (7.2)
Global 
summary
75.2 (28.3) 72.5 (22.9)
HMW, high molecular weight; LMW, low molecular weight; UAS, 
upper airway symptoms; LAS, lower airways symptoms; RAI, respiratory 
allergy impact. Results are means (standard deviations), *P < 0.05, no 
indicator = P-value NS.
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In our study population, laryngeal symptoms were 
associated with impairments in rhinitis-specific QOL. 
Laryngeal symptoms were reported as more frequent 
among patients with allergic rhinitis than in patients 
with non-allergic rhinitis and were negatively associated 
with voice-related QOL [29]. The number of positive 
skin prick test results to common allergens was posi-
tively associated with greater voice impairments among 
patients who presented to a rhinology clinic in the UK 
without specific voice-related complaints [30].
We acknowledge that these findings should be con-
firmed in a larger study, particularly with regard to poten-
tial differences between subjects with OA and WEA. Also, 
occupational surveys should consider including assess-
ments for pharyngeal, laryngeal and sinus symptoms in 
addition to nasal symptoms when examining the effects 
of environmental and occupational noxious exposures.
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